Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice

Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice

Bibliographic Details
Main Authors:	Baek, R, Kasperzyk, J, Platt, F, Seyfried, T
Format:	Conference item
Published:	2005

Similar Items

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
by: Baek, R, et al.
Published: (2008)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
by: Baek, R, et al.
Published: (2004)

Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
by: Kasperzyk, J, et al.
Published: (2002)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
by: Kasperzyk, J, et al.
Published: (2005)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
by: Kasperzyk, J, et al.
Published: (2004)

Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
by: Kasperzyk, J, et al.
Published: (2005)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
by: Kasperzyk, J, et al.
Published: (2004)

Effects of substrate deprivation therapy on brain lipids in neonatal GML storage disease mice
by: Kasperzyk, J, et al.
Published: (2003)

Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
by: Denny, C, et al.
Published: (2010)

Therapeutic assessment of substrate deprivation using NB-DGJ in GM1 storage disease mice
by: Seyfried, T, et al.
Published: (2003)

Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
by: Yi-Chen Hsieh, et al.
Published: (2022-09-01)

Substrate reduction therapy in Sandhoff disease: Evidence for improvement in nervous function in patients treated with miglustat
by: Lachmann, R, et al.
Published: (2006)

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
by: Andersson, U, et al.
Published: (2004)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
by: Ranes, M, et al.
Published: (2001)

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.
by: Jeyakumar, M, et al.
Published: (2001)

GM1 ganglioside-independent intoxication by Cholera toxin
by: Cervin, J, et al.
Published: (2018)

The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
by: Sandro Sonnino
Published: (2023-09-01)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
by: Pshezhetsky, A, et al.
Published: (2017)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
by: Pshezhetsky, A, et al.
Published: (2017)

Enhanced Susceptibility to Chemoconvulsant-Induced Seizures in Ganglioside GM3 Synthase Knockout Mice
by: Fu-Lei Tang, et al.
Published: (2020-07-01)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
by: Suman Chowdhury, et al.
Published: (2022-01-01)

CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease
by: Rui Wang, et al.
Published: (2023-05-01)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Huebecker, M, et al.
Published: (2019)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
by: Maria L. Allende, et al.
Published: (2023-12-01)

Dietary gangliosides rescue GM3 synthase deficiency outcomes in mice accompanied by neurogenesis in the hippocampus
by: Jin-ichi Inokuchi, et al.
Published: (2024-07-01)

Disordered testosterone transport in mice lacking the ganglioside GM2/GD2 synthase gene
by: Koichi Furukawa, et al.
Published: (2023-09-01)

Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
by: te Vruchte, D, et al.
Published: (2010)

Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease
by: Rui Wang, et al.
Published: (2023-08-01)

Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
by: Somogyi, A, et al.
Published: (2018)

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.
by: Elliot-Smith, E, et al.
Published: (2008)

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
by: Luis E. Fernandez, et al.
Published: (2010-01-01)

Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
by: Melanie Alpaugh, et al.
Published: (2017-10-01)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
by: Harlalka, G, et al.
Published: (2013)

GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells
by: Sonia Bergante, et al.
Published: (2018-01-01)

Anti-Inflammatory Effects of GM1 Ganglioside on Endotoxin-Induced Uveitis in Rats
by: Tzu-Heng Weng, et al.
Published: (2022-05-01)

The Role of Lipid Environment in Ganglioside GM1-Induced Amyloid β Aggregation
by: Vladimir Rudajev, et al.
Published: (2020-09-01)

Substrate reduction therapy
by: Platt, F, et al.
Published: (2007)

Substrate reduction therapy.
by: Platt, F, et al.
Published: (2008)

Chimeric antigen receptor T cells targeting the GM3(Neu5Gc) ganglioside
by: Julia Heinzelbecker, et al.
Published: (2024-02-01)

MRS reveals additional hexose N-acetyl resonances in the brain of a mouse model for Sandhoff disease.
by: Lowe, J, et al.
Published: (2005)